Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients

Despite experimental evidence of beneficial metabolic, antiatherosclerotic and antiinflammatory effects of the 30 kDa adipokine, adiponectin, maintenance hemodialysis (MHD) patients with high adiponectin blood levels have paradoxically high mortality rates. We aimed to examine the direction of the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Beberashvili, Ilia, Cohen-Cesla, Tamar, Khatib, Amin, Hamad, Ramzia Abu, Azar, Ada, Stav, Kobi, Efrati, Shai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079690/
https://www.ncbi.nlm.nih.gov/pubmed/33907250
http://dx.doi.org/10.1038/s41598-021-88558-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079690/
https://www.ncbi.nlm.nih.gov/pubmed/33907250
http://dx.doi.org/10.1038/s41598-021-88558-0

Ejemplares similares